GLPBio

Mesna

Catalog No.: GC12930Purity:>98.00%Synonyms: Coenzyme M, HS-CoM, 2-Mercaptoethanesulfonate, UCB 3983
Mesna(メスナ)は、細胞保護効果を持つ抗酸化物質です。メスナは、化学療法の毒性に対する全身保護剤として広く使用されています。メスナは、シクロホスファミドによって誘発される出血性膀胱炎を軽減するためにも使用されます。

製品は研究用途にのみ使用できます。人体には使用できません。患者への販売は行っておりません。


Mesna
Cas No.: 19767-45-4
10mM (in 1mL Water)In Stock
$35.00
1
500mgIn Stock
$25.00
1
5gIn Stock
$34.00
1
5gIn Stock
$34.00
1
10gIn Stock
$55.00
1
10gIn Stock
$55.00
1

引用文献 (Citations)

1 publications本製品を使用した研究者による文献

製品説明 (Description)

Mesna, is a synthetic small molecule, widely used as a systemic protective agent against chemotherapy toxicity, but is primarily used to reduce hemorrhagic cystitis induced by cyclophosphamide.Target: in vitro: MESNA had no effect on the qualitative and quantitative characteristics of the indicated processes in both the types of the doxorubicin sensitive cells. The combined use of doxorubicin and phosphamide or cyclophosphane the use of MESNA for lowering the urotoxic action of oxazophosphorines had no effect on the biological efficacy of doxorubicin[3].in vivo: AMH-positive follicles were significantly decreased after cisplatin administration, which was significantly reversed when mesna was co-administered with cisplatin. The end product of lipid peroxidation, malondialdehyde (MDA), was significantly increased, but the anti-oxidative enzymatic activity of superoxide dismutase (SOD) and glutathione (GSH) were significantly decreased in cisplatin groups when compared with NS group. In contrast, after co-administration of cisplatin with mesna, MDA was significantly decreased whereas the activity of SOD and the concentration of GSH were increased. Moreover, mesna did not decrease the anti-tumor property of cisplatin in HePG2 cell lines[2]. After head trauma, tissue malondialdehyde levels increased; these levels were significantly decreased by MESNA administration. Caspase-3 levels were increased after trauma, but no effect of MESNA was determined in caspase-3 activity[1].Clinical trial: Effects of Mesna on Homocysteine in Kidney Failure . Phase2

References:
[1]. Yilmaz ER, Kertmen H, Gürer B, The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats. Acta Neurochir (Wien). 2013 Jan;155(1):141-9; discussion 149.
[2]. Li X, Yang S, Lv X, The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats. J Gynecol Oncol. 2013 Apr;24(2):177-85.
[3]. Bogush TA, Smirnova GB, Chmutin EF, Effect of MESNA on intracellular accumulation of doxorubicin and its interaction with DNA. Antibiot Khimioter. 1994 Sep-Oct;39(9-10):30-5.

製品資料 (Product Documents)

Purity:>98.00%Appearance:A solid

化学的性質 (Chemical Properties)

CAS番号
19767-45-4
同義語
Coenzyme M, HS-CoM, 2-Mercaptoethanesulfonate, UCB 3983
化学名
sodium;2-sulfanylethanesulfonate
SMILES
C(CS(=O)(=O)[O-])S.[Na+]
分子式
C2H5NaO3S2
分子量
164.18
溶解性
≥ 8.05mg/mL in DMSO
保存条件
Store at -20°C
一般的な注意事項
製品の溶解性データに基づいて適切な溶媒を選択してください。調製後は、凍結融解の繰り返しを避けるため、ストック溶液を小分けしてください。
ストック溶液は、-80°Cで保存する場合は6か月以内、-20°Cで保存する場合は1か月以内に使用してください。
溶解性を高めるには、チューブを37°Cに温め、適切な時間超音波処理してください。
配送条件
評価用サンプルは保冷剤とともに発送します。その他の容量は室温で発送し、ご要望に応じて保冷剤を同梱します。

計算ツール (Calculators)モル濃度 / 希釈 / 分子量 / 単位変換 / in vivo製剤 / 溶解度

g/mol

Reviews

Review for Mesna

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%